US 8916175
Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection
granted A61KA61K39/12A61K39/25
Quick answer
US patent 8916175 (Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K39/12, A61K39/25, A61P, A61P31/12